BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 27538376)

  • 1. Assessment of the low inhibitory specificity of oxamate, aminooxyacetate and dichloroacetate on cancer energy metabolism.
    Moreno-Sánchez R; Marín-Hernández Á; Del Mazo-Monsalvo I; Saavedra E; Rodríguez-Enríquez S
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3221-3236. PubMed ID: 27538376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Non-flux-Controlling Enzymes Deters Cancer Glycolysis by Accumulation of Regulatory Metabolites of Controlling Steps.
    Marín-Hernández Á; Rodríguez-Zavala JS; Del Mazo-Monsalvo I; Rodríguez-Enríquez S; Moreno-Sánchez R; Saavedra E
    Front Physiol; 2016; 7():412. PubMed ID: 27721794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting aspartate aminotransferase in breast cancer.
    Thornburg JM; Nelson KK; Clem BF; Lane AN; Arumugam S; Simmons A; Eaton JW; Telang S; Chesney J
    Breast Cancer Res; 2008; 10(5):R84. PubMed ID: 18922152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation.
    Marín-Hernández A; Gallardo-Pérez JC; López-Ramírez SY; García-García JD; Rodríguez-Zavala JS; Ruiz-Ramírez L; Gracia-Mora I; Zentella-Dehesa A; Sosa-Garrocho M; Macías-Silva M; Moreno-Sánchez R; Rodríguez-Enríquez S
    Arch Toxicol; 2012 May; 86(5):753-66. PubMed ID: 22349057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
    Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
    Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic modeling of glucose central metabolism in hepatocytes and hepatoma cells.
    Marín-Hernández Á; Gallardo-Pérez JC; Reyes-García MA; Sosa-Garrocho M; Macías-Silva M; Rodríguez-Enríquez S; Moreno-Sánchez R; Saavedra E
    Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129687. PubMed ID: 32712171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the malate-aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection.
    Støttrup NB; Løfgren B; Birkler RD; Nielsen JM; Wang L; Caldarone CA; Kristiansen SB; Contractor H; Johannsen M; Bøtker HE; Nielsen TT
    Cardiovasc Res; 2010 Nov; 88(2):257-66. PubMed ID: 20562422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic consequences of lactate dehydrogenase inhibition by oxamate in hyperglycemic proximal tubular cells.
    Wang Z; Nielsen PM; Laustsen C; Bertelsen LB
    Exp Cell Res; 2019 May; 378(1):51-56. PubMed ID: 30836064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy Metabolism Drugs Block Triple Negative Breast Metastatic Cancer Cell Phenotype.
    Pacheco-Velázquez SC; Robledo-Cadena DX; Hernández-Reséndiz I; Gallardo-Pérez JC; Moreno-Sánchez R; Rodríguez-Enríquez S
    Mol Pharm; 2018 Jun; 15(6):2151-2164. PubMed ID: 29746779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitization of tumor cells to glycolytic inhibitors.
    Liu H; Hu YP; Savaraj N; Priebe W; Lampidis TJ
    Biochemistry; 2001 May; 40(18):5542-7. PubMed ID: 11331019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of three modifiers of glycolysis on ATP, lactate, hypoxia, and growth in human tumor cell lines in vivo.
    Yaromina A; Meyer S; Fabian C; Zaleska K; Sattler UG; Kunz-Schughart LA; Mueller-Klieser W; Zips D; Baumann M
    Strahlenther Onkol; 2012 May; 188(5):431-7. PubMed ID: 22349632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression.
    Chaube B; Malvi P; Singh SV; Mohammad N; Meena AS; Bhat MK
    Oncotarget; 2015 Nov; 6(35):37281-99. PubMed ID: 26484566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactate Dehydrogenase Inhibition With Oxamate Exerts Bone Anabolic Effect.
    Hollenberg AM; Smith CO; Shum LC; Awad H; Eliseev RA
    J Bone Miner Res; 2020 Dec; 35(12):2432-2443. PubMed ID: 32729639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
    Zhang W; Hu X; Zhou W; Tam KY
    J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
    Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
    Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective inhibition of nasopharyngeal carcinoma in vitro and in vivo by targeting glycolysis with oxamate.
    Li X; Lu W; Hu Y; Wen S; Qian C; Wu W; Huang P
    Int J Oncol; 2013 Nov; 43(5):1710-8. PubMed ID: 23982861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dichloroacetate in canine prostate adenocarcinomas and transitional cell carcinomas in vitro.
    Harting T; Stubbendorff M; Willenbrock S; Wagner S; Schadzek P; Ngezahayo A; Murua Escobar HM; Nolte I
    Int J Oncol; 2016 Dec; 49(6):2341-2350. PubMed ID: 27748833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells.
    Liu X; Yang Z; Chen Z; Chen R; Zhao D; Zhou Y; Qiao L
    Oncol Rep; 2015 Jan; 33(1):157-62. PubMed ID: 25394466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment.
    Ruggieri V; Agriesti F; Scrima R; Laurenzana I; Perrone D; Tataranni T; Mazzoccoli C; Lo Muzio L; Capitanio N; Piccoli C
    Oncotarget; 2015 Jan; 6(2):1217-30. PubMed ID: 25544754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.